FTXH

ETF / Mutual Fund
NASDAQ
First Trust NASDAQ Pharmaceuticals ETF
Price Chart
Overview

About FTXH

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

AUM
Volume
1.5M
Avg. Volume
545.7K
Expense Ratio
0.60%

Fund Information

Exchange
NASDAQ
Sector
Risk & Correlation Analysis
Market Correlation
0.51
Low Correlation
Volatility
Low (0.14)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for FTXH.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, FTXH shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM
Volume1.5M
Expense Ratio0.60%
Important Dates
Next Dividend
Next Earnings

PortfolioPilot Analysis

Get AI-powered insights on how FTXH fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025